Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Drug-Resistant Bacteria Spread Regionally Through Hospitals
Vancomycin-resistant enterococci increase at one hospital increases prevalence in other hospitals

TUESDAY, Aug. 6 (HealthDay News) -- An increase in vancomycin-resistant enterococci (VRE) colonization prevalence correlates with increased prevalence in other hospitals, with larger hospitals having greater effects on other hospitals, according to a study published in the August issue of the American Journal of Infection Control.

Bruce Y. Lee, M.D., M.B.A., from the University of Pittsburgh, and colleagues quantified the degree and speed at which changes in VRE colonization prevalence in a hospital may affect prevalence in other local hospitals using the Regional Healthcare Ecosystem Analyst, an agent-based model of patient flow among all Orange County, Calif., hospitals and communities.

The researchers found that as a result of a sustained 10 percent increase in VRE colonization prevalence in any one hospital there was a 2.8 percent average relative increase in VRE prevalence in all other hospitals. To fully manifest, the effects took 1.5 to more than 10 years. The effect on other hospitals tended to be greater for larger hospitals.

"Knowing a hospital's connections with other health care facilities via patient sharing can help determine which hospitals to include in a surveillance or control program," the authors write. "Because the effects of VRE colonization prevalence change in one hospital can take months to years to fully manifest, patience and long-term follow-up may be essential when tracking VRE control."

Abstract
Full Text



Copyright © 2013 HealthDay. All rights reserved.

July 23, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Online Reviews Show Patients Value Docs' Interpersonal Skills

Physician Offices Investing in Patient Portals for EHRs

Preemptive Celecoxib Cuts Post-Op Face-Lift Surgery Pain

Decreased Vision Tied to Unemployment

Albumin, Creatinine Blood Tests Might Help Predict ALS Survival

Gene Marker May Predict Breast Cancer Response to Tamoxifen CME